Hate burpees? Try these 3 low-impact variations

Burpees don’t have to be the exercise you dread. Try these low-impact variations which will help make the full-body movement more achievable. Just the word burpee is enough to make most people want to hide. The full-body cardio move is physically and mentally challenging – involving throwing your entire body weight to the floor and jumping up and down. We’re knackered […]

» Read more

China Reports 1439 New COVID Cases for September 7 vs 1695 a Day Earlier

SHANGHAI (Reuters) – China reported 1,439 COVID-19 infections on Sept. 7, of which 280 were symptomatic and 1,159 were asymptomatic, the National Health Commission said on Thursday. That is compared with 1,695 cases a day earlier – 380 symptomatic and 1,315 asymptomatic infections, which China counts separately. There were no new deaths, same as a day earlier, keeping the nation’s […]

» Read more

What Pet Dangers Are in Your Garage?

It’s not uncommon for pets to accompany their pet parents to the garage when  getting ready for a car ride (paws crossed for the dog park and not the vet), sneaking to check out something cool or simply just passing through. Unfortunately, it is also not uncommon for our furry friends to get into hidden hazards in the garage that […]

» Read more

Researchers visualize α-synuclein pathology in living patients with a neurodegenerative disorder

Multiple system atrophy (MSA) is a neurodegenerative disorder characterized by the aggregation of α-synuclein in the brain. Now, scientists from Japan, in collaboration with three pharmaceutical companies, have developed a radioligand that facilitates the imaging of α-synuclein aggregates in patients with MSA. Their findings have the potential to completely change the scenario of diagnosing neurodegenerative diseases. α-synuclein is a neuronal […]

» Read more

10,000 steps vs. power walking: Are they equally beneficial?

A large new study investigates the health effects of walking 10,000 steps a day or less. The researchers found that the risk of premature death decreases with every 2,000 steps people take. They also found a correlation between the number of daily steps and a reduced risk of developing dementia, heart disease, and cancer. Power-walking also adds additional benefits and […]

» Read more

New antiviral mechanism of action for an FDA-approved thiopurine known as 6-thioguanine

In a recent study published in PLoS Pathogens, researchers described a novel antiviral mechanism of action for an FDA (food and drug administration)-approved thiopurine known as 6-thioguanine (6-TG). Study: Thiopurines inhibit coronavirus Spike protein processing and incorporation into progeny virions. Image Credit: Bacsica/Shutterstock Background The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has spurred efforts to repurpose drugs to […]

» Read more

Addiction management is key to treating heart infection in people who inject drugs

Managing a potentially deadly heart infection is complex in people who inject drugs, including opioids, stimulants, and others, and requires a unique approach to care including consultation with an addiction specialist, according to a new American Heart Association Scientific Statement published today in the Association’s flagship journal Circulation. Infective endocarditis is caused by bacteria that enter the bloodstream and settle […]

» Read more

Biological effects of nanoplastics in paints

The high rate of plastic usage throughout the world and its subsequent uncontrolled deposition in landfills and water bodies have a significant effect on the environment. Although plastics are resistant to biodegradation, larger plastics are converted to smaller pieces when subjected to mechanical abrasion in hydrolytic surroundings or under ultraviolet (UV) irradiation. When disintegrated plastics reach between one micrometer (µm) […]

» Read more

FDA OKs First Targeted Agent, Pemigatinib, for Rare Blood Cancer

The US Food and Drug Administration (FDA) has approved pemigatinib (Pemazyre), a selective fibroblast growth factor receptor inhibitor, for adults with relapsed or refractory myeloid/lymphoid neoplasms with FGFR1 rearrangement. The approval follows priority review of a supplemental New Drug Application submitted by the drug maker, Incyte, and marks the second indication for pemigatinib. The drug previously received accelerated FDA approval […]

» Read more
1 347 348 349 350 351 1,330